Table 2 Association Between risk genotypes of ADRA2A, DRD2 and SLC6A4 genes and ADHD with Symptom Domains.

All ADHD(160)

1.76^*

(1.12–2.77)

2.07^*

(1.27–3.37)

2.00^*

(1.23–3.23)

Inattention(141)^d

1.91^*

(1.19–3.07)

2.05^*

(1.26–3.36)

2.19^*

(1.32–3.63)

Hyperactivity/impulsivity(78)^e

2.18^*

(1.21–3.94)

2.28^*

(1.24–4.18)

2.37^*

(1.29–4.34)

ODD(39)^f

1.53

(0.72–3.25)

1.79

(0.82–3.91)

2.07

(0.92–4.66)

Control(225)

1

1

1

All ADHD(163)

2.22^†

(1.11–4.46)

2.11^†

(1.01–4.06)

2.38^†

(1.33–5.83)

Inattention(143)^d

2.11^†

(1.01–4.06)

2.42^†

(1.15–5.11)

2.11^†

(1.03–4.39)

Hyperactivity/impulsivity(78)^e

1.73

(0.76–3.94)

1.83

(0.79–4.26)

1.81

(0.78–4.19)

ODD(36)^f

1.58

(0.52–4.77)

1.78

(0.57–5.59)

1.63

(0.53–5.00)

Control(222)

1

1

1

All ADHD(167)

1.73^†

(1.07–2.78)

1.51

(0.91–2.51)

1.55

(0.93–2.59)

Inattention(153) ^d

1.58

(0.97–2.56)

1.40

(0.84–2.42)

1.42

(0.83–2.43)

Hyperactivity/impulsivity(85)^e

1.62

(0.91–2.88)

1.56

(0.85–2.84)

1.48

(0.80–2.73)

ODD(39)^f

2.18^†

(1.04–4.56)

2.38^†

(1.09–5.19)

2.46^†

(1.10–5.50)

Control(222)

1

1

1